403 related articles for article (PubMed ID: 6451335)
1. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.
Nath I; Van Rood JJ; Mehra NK; Vaidya MC
Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335
[TBL] [Abstract][Full Text] [Related]
2. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR
Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK
Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762
[TBL] [Abstract][Full Text] [Related]
4. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.
Nath I; Singh R
Clin Exp Immunol; 1980 Sep; 41(3):406-14. PubMed ID: 7002396
[TBL] [Abstract][Full Text] [Related]
5. The role of macrophages in the lymphoproliferative response to Mycobacterium leprae in vitro.
Hirschberg H
Clin Exp Immunol; 1978 Oct; 34(1):46-51. PubMed ID: 373933
[TBL] [Abstract][Full Text] [Related]
6. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR
Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597
[TBL] [Abstract][Full Text] [Related]
7. Concanavalin A induced suppressor activity in human leprosy.
Nath I; Narayanan RB; Mehra NK; Sharma AK; Gupte MD
J Clin Lab Immunol; 1979 Nov; 2(4):319-24. PubMed ID: 161322
[TBL] [Abstract][Full Text] [Related]
8. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
9. Antigen specific macrophage-lymphocyte interaction in lepromatous leprosy.
Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
J Clin Lab Immunol; 1984 Apr; 13(4):189-94. PubMed ID: 6376810
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
11. Studies on the defect in cell-mediated immunity in lepromatous leprosy using HLA-D-identical siblings. Absence of circulating suppressor cells and evidence that the defect is in the T-lymphocyte, rather than the monocyte, population.
Stoner GL; Mshana RN; Touw J; Belehu A
Scand J Immunol; 1982 Jan; 15(1):33-48. PubMed ID: 6176016
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro.
Kaplan G; Gandhi RR; Weinstein DE; Levis WR; Patarroyo ME; Brennan PJ; Cohn ZA
J Immunol; 1987 May; 138(9):3028-34. PubMed ID: 3106496
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte transformation test in lepromatous leprosy patients and their healthy siblings.
Sengupta SR; Yemul VL; Dhole TN
Lepr India; 1983 Apr; 55(2):261-4. PubMed ID: 6579324
[TBL] [Abstract][Full Text] [Related]
14. Effect of Mycobacterium leprae on lymphocyte proliferation: suppression of mitogen and antigen responses of human peripheral blood mononuclear cells.
Touw J; Stoner GL; Belehu A
Clin Exp Immunol; 1980 Sep; 41(3):397-405. PubMed ID: 6449337
[TBL] [Abstract][Full Text] [Related]
15. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
16. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
17. Comparison of various preparations of Mycobacterium leprae and other mycobacteria by lymphocyte stimulation.
Bjune G
Int J Lepr Other Mycobact Dis; 1978; 46(3-4):386-93. PubMed ID: 83309
[TBL] [Abstract][Full Text] [Related]
18. The immunobiology of leprosy.
Kaplan G; Cohn ZA
Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
[TBL] [Abstract][Full Text] [Related]
19. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
Laal S; Mishra RS; Nath I
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):481-93. PubMed ID: 2958570
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
